Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EMERALD RESOURCES NL Regulatory Filings 2021

May 4, 2021

64849_rns_2021-05-04_f1a3c6b3-2c74-4c95-9c0e-a7098912843d.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Form 603

Corporations Act 2001 Section 671B

Notice of initial substantial holder

To Company Name/Scheme EMERALD RESOURCES NL
ACN/ARSN 009 795 046
1. Details of substantial holder (1)
Name REALEE PTY LTD (GROUP)
ACN/ARSN (if applicable) 115 504 035

The holder became a substantial holder on 18/12/2020

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4) Number of securities Person's votes (5) Voting power (6)
ORDINARY SHARES 27,575,861 27,575,861 5.35%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest Nature of relevant interest (7) Class and number of securities
REALEE PTY LTD (GROUP) INDIRECT 27,575,861
Ordinary Shares

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant
interest
Registered holder of
securities
Person entitled to be
registered as holder (8)
Class and number of securities
REALEE PTY LTD REALEE PTY LTD REALEE PTY LTD 2,491,322
Ord. Shares
RYAN LEE RYAN LEE RYAN LEE 181,361
Ord. Shares
CHENELLE SHEN CHENELLE SHEN CHENELLE SHEN 169,844
Ord. Shares
SHL PTY LTD SHL PTY LTD SHL PTY LTD 24,733,334 Ord. Shares

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holder of relevant
interest
Date of acquisition Consideration (9) Class and number of securities
Cash Non-cash
(REFER ATTACHED
APPENDIX A)

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicabte) Nature of association

7. Addresses

The addresses of persons named in this form are as follows:

Name Address
RE.ALEE PIY LTD (GROUP) PO Box 2705, Cloisters Square, perth WA 6g50

Signature

print name RYA}I LEE capacity DIRECTOR
sign here date 04 / OS / 2021

DIRECNONS

  • (1) manager lf there are a number of substantial holders with similar or related relevanl interests (eg. a corporation and its related corporations, or the persons and trustee of an equity trust)' the names could be included in an annexure io the form. lf the relevant interests of a group of are essentially similal, they may be refened to throughout the form as a specifically nar"o !ffi it tne memuersni;;i;;;; group, with the names and addresses of members is clearly iet out in pamgrapn 7 of the form.
  • (2) see the definition of 'associate" in section g of the corporations Act 2001.
  • (3) See the definition of "relevant interest" in sections 608 and 6718(7) of the Corporations Act 2001.
  • t4) The voting shares of a company constitute one dass unless divided into separate classes.
  • (5) The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant interest in.
  • (6) The person's votes divided by the total votes in the body corporate or scheme multiplied by .100.
  • (7) lnclude detaits of:
  • (a) any relevant agreement or other circumstances by which the relevant interest was acquired. lf subsection 6718(4) applies, a copy of any document setting out the terms of any relevant agreement, ,nJ " "irt r"nt.by the person living fun and accurate details oi arry contract, scheme or anangement, must acc,ompany fris torm, iogetneiwittr a written stitemenicertirying this contract, scheme or anangement; and
  • (b) any qualification of the power of a person to exercise, control the exercise o( or influence the exercise of, the voting powers or disposal of the securities to which ihe relevant interest l.er"t"s tinoi""iing cleirly the particutar ieeurities to which the qualification appties).

see the definilion of "relevant agreement', in section g of the corporations Act 200.1.

  • (8) !,lf*?:**J""ti'l holder is unable to determine the identity of the person { eg. if the retevant interest arises because of an option) write
  • (9) Details of the consideration must include any and all benefits, money and other, that any pe6on from whom a relevant interest was the acquired happening has, or may, become entitled to re&ive in relalion 6 th;i;cqui"itionl o"t il. mList be inauaeo even if the benefit is conditionat on relation or not of a contingency. Details must be included ot a"v-ue"eii paid on behalf of the substantial holder or ib associate in to the acquisitions, even if they are not paid oirectry to ure pe[* iro, the relevant inler."i*". acquired.
DATE ORDINARY SHARES QTY TOTAL COST
27/11/2020 EMR 41,288 \$
25,814.50
27/11/2020 EMR 120,607 \$
77,197.98
1/12/2020 EMR 50,000 \$
29,009.50
2/12/2020 EMR 10,000 \$
6,109.50
8/12/2020 EMR 136,924 \$
87,640.86
9/12/2020 EMR 152,798 \$
99,328.20
9/12/2020 EMR 164,992 \$
107,023.31
14/12/2020 EMR 60,000 \$
39,009.50
14/12/2020 EMR 100,000 \$
65,009.50
14/12/2020 EMR 105,312 \$
68,883.55
18/12/2020 EMR 77,228 \$
53,296.82
24/12/2020 EMR 157,196 \$
110,824.66
30/12/2020 EMR 156,446 \$
134,897.24
30/12/2020 EMR 51,485 \$
44,544.03
31/12/2020 EMR 348,861 \$
291,308.44
8/01/2021 EMR 110,000 \$
97,879.47
13/01/2021 EMR 62,954 \$
50,243.14
25/01/2021 EMR 76,139 \$
59,397.92
27/01/2021 EMR 15,371 \$
11,845.17
3/02/2021 EMR 188,870 \$
157,670.43
8/02/2021 EMR 63,291 \$
51,689.58
18/02/2021 EMR 41,560 \$
31,595.06
3/03/2021 EMR 100,000 \$
76,509.50
5/03/2021 EMR 100,000 \$
76,009.50
2,491,322 \$
1,852,737.36

REALEE PTY LTD:

RYAN LEE:
DATE ORDINARY SHARES QTY TOTAL COST
29/12/2020 EMR 25,302 \$ 18,498.11
18/01/2021 EMR 43,191 \$ 34,802.70
27/01/2021 EMR 3,050 \$ 2,353.20
3/02/2021 EMR 6,604 \$ 5,448.30
8/02/2021 EMR 4,861 \$ 3,933.06
9/02/2021 EMR 21,392 \$ 17,230.56
10/02/2021 EMR 4,802 \$ 3,865.61
15/02/2021 EMR 20,547 \$ 15,029.26
29/03/2021 EMR 40,324 \$ 31,288.60
31/03/2021 EMR 11,288 \$ 8,758.71
181,361 \$ 141,208.11
CHENELLE SHEN:
DATE ORDINARY SHARES QTY TOTAL COST
30/11/2020 EMR 39,683 \$
25,027.58
11/12/2020 EMR 17,615 \$
11,303.55
22/12/2020 EMR 60,510 \$
41,179.76
29/12/2020 EMR 52,036 \$
38,292.35
169,844 \$
115,803.24
SHL PTY LTD:
DATE ORDINARY SHARES QTY CAPITAL RECON.
27/03/2020 EMR 24,733,334 CONSOLIDATION